ABOUT US

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel

Our team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. We partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

 

 

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel

Our team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. We partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

OUR STORY

aMoon was co-founded and is anchored by Marius Nacht, co-founder of cybersecurity giant Check Point Software Technologies (NASDAQ: CHKP), after accompanying his beloved father through an agonizing battle with cancer. Throughout this journey he discovered a number of innovative life sciences solutions with the potential to save many lives on a global scale. Sadly, much of this potential remains unrealized due to lack of funding and various bottlenecks. Marius recognized that the convergence of technology and healthcare could unleash a transformation that could surpass the cybersecurity industry, which he helped build over the past 25 years.

 

 

OUR STORY

aMoon was co-founded and is anchored by Marius Nacht, co-founder of cybersecurity giant Check Point Software Technologies (NASDAQ: CHKP) after accompanying his beloved father through an agonizing battle with cancer. Throughout this journey he discovered a number of innovative life sciences solutions with the potential to save many lives on a global scale. Sadly, much of this potential remains unrealized due to lack of funding and various bottlenecks. Marius recognized that the convergence of technology and healthcare could unleash a transformation that could surpass the cybersecurity industry, which he helped build over the past 25 years.

 

OUR STORY

aMoon was co-founded and is anchored by Marius Nacht, co-founder of cybersecurity giant Check Point Software Technologies (NASDAQ: CHKP), after accompanying his beloved father through an agonizing battle with cancer. Throughout this journey he discovered a number of innovative life sciences solutions with the potential to save many lives on a global scale. Sadly, much of this potential remains unrealized due to lack of funding and various bottlenecks. Marius recognized that the convergence of technology and healthcare could unleash a transformation that could surpass the cybersecurity industry, which he helped build over the past 25 years.

 

aMoon-1257

OUR FUNDS

aMoon Logos update-02

An early-stage healthtech & life sciences fund backed exclusively by Marius Nacht, invested in 16 portfolio companies and closed to new investments.

 

aMoon Logos update-01

A mid-to-late stage fund investing in biopharma, medical device and digital health companies. 

 

aMoon Logos update-03

A new fund focused on early-stage highly disruptive healthcare technologies, open exclusively to aMoon II investors

OUR FUNDS

An early-stage healthtech & life sciences fund backed exclusively by Marius Nacht, invested in 16 portfolio companies and closed to new investments.

A mid-to-late stage fund investing in biopharma, medical device and digital health companies. 

A new fund focused on early-stage highly disruptive healthcare technologies, open exclusively to aMoon II investors.

oo1 copy

WHY HEALTHTECH? WHY ISRAEL? WHY NOW?

 

Over the past two decades the traditional world of healthcare and technology have begun converging at a dizzying pace. aMoon was created to capitalize on the investment opportunities that will emerge from this fundamental transformation. Using the team's global network, the Fund's objective is to generate strong investment returns by partnering with promising mid-late-stage companies in Israel and in select other global centers of Healthtech innovation. We believe these companies hold great promise to accelerate cures and confront the cost challenges facing the global healthcare industry.  

 

Over the past two decades the traditional worlds of healthcare and technology have begun converging at a dizzying pace. aMoon was created to capitalize on the investment opportunities that will emerge from this fundamental transformation. Using the team’s global network, the Fund’s objective is to generate strong investment returns by partnering with promising mid-late-stage companies in Israel and in select other global centers of Healthtech innovation. We believe these companies hold great promise to accelerate cures and confront the cost challenges facing the global healthcare industry.